Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of$ 0.27. This compares to loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.41%. A quarter ago, it was expected that this orthopedic medical device maker would post a loss of$ 0.29 per share when it actually produced a loss of $0.34, delivering a surprise of -17.24%.Over the last four qu ...